Kim, Daewook,Lee, Hyesun,Kim, Min,Kim, Sujeong,Choi, Heonsik,Choi, Kyoungbaek,Lee, Hyeonyoul
申请号：
AU2016216223
公开号：
AU2016216223A1
申请日:
2016.02.05
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
The present invention relates to a cell therapeutic agent for treating inflammatory diseases caused by hyper-immune responses and, more specifically, to a composition for treating inflammatory diseases caused by hyper-immune responses, containing: (i) cartilage cells or cells, which can be differentiated into cartilage cells； and (ii) cartilage cells into which a gene encoding TGF-β is introduced or cells, which can be differentiated into cartilage cells into which a gene encoding TGF-β is introduced.
